Company news
Heidelberg Pharma Ag (XETR:HPHA) news
Heidelberg Pharma Ag news releases on 6ix. Latest, Sep 24, 2026: Heidelberg Pharma Presented New Clinical Data for Lead ATAC Candidate Pamlectabart Tismanitin…
Press releases & updates
Heidelberg Pharma Presented New Clinical Data for Lead ATAC Candidate Pamlectabart Tismanitin at IMS Annual Meeting 2026
September 24, 2026
Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026
September 7, 2026
Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates
August 28, 2026
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
August 26, 2026
Heidelberg Pharma Reports on First Half-Year 2026 and the Positive Course of Business
July 15, 2026
Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2026
June 23, 2026
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026
April 29, 2026
Heidelberg Pharma Announces Change in Executive Board
April 17, 2026
Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101
April 9, 2026
Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
April 4, 2026
Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
March 26, 2026
Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
March 18, 2026
Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
November 24, 2025
Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar
November 3, 2025
Heidelberg Pharma to Present at the Life Sciences Virtual Investor Forum June 12th
June 6, 2025